Add to MyYahoo RSS

Prostate Cancer News

News on Prostate Cancer continually updated from thousands of sources around the net.

3 hrs ago | Medical News

Intravesical prostatic protrusion predicts post-surgery incontinence

The length of intravesical prostatic protrusion in men undergoing radical prostatectomy predicts the likelihood that they will develop incontinence following surgery, Korean researchers have shown.


Related Topix: South Korea, World News, Health, Medicine

7 hrs ago | Packer

Pom Wonderful, FTC argue label language in appeals court

Years of legal language will be reduced to two 15-minute statements as an appeals court hears lawyers for Pom Wonderful and the Federal Trade Commission describe advertising claims the government contends are illegal.


Related Topix: Healthcare Law, Law, Health, Roll International, Household Products, Marketing

16 hrs ago | CBS Local

Rush Using New More Accurate Tests For Prostate Cancer

Doctors at a Chicago hospital have recently started using new technology to more accurately detect possible problem areas on men's prostates.


Related Topix: Health, Rush University, Medicine, Urology

18 hrs ago |

Discover if you are at risk from prostate cancer for free in Dorchester

A SIMPLE procedure to test if men are at risk from prostate cancer is being offered for free in Dorchester .


Related Topix: Cancer, Medicine, Health

18 hrs ago | Harwich and Manningtree Standard

a Five-Year battle to remove an illegal - shanty' extension to a building in Mistley has ended.

A CHARITABLE garage worker has taken things a step further in his quest to raise money for Cancer Research - by dressing up as a woman.


Related Topix: Health

19 hrs ago | Medical News Today

Chronic prostate inflammation tied to nearly double risk of prostate cancer

For your information: MNT accounts were not affected by the recent Heartbleed bug, as we were not running a vulnerable version of OpenSSL.


Related Topix: Health

Mon Apr 21, 2014

Nikkei Net Interactive

Astellas' operating profit seen up 14% in fiscal 2013

Astellas Pharma Inc.'s operating profit likely grew 14% in the year ended March 31 as sales of its Xtandi prostate cancer treatment jumped in the U.S. The drugmaker also saw its profitability improve in Japan, helping it achieve a third straight year of operating profit gains.


Daily Mail

Me and My Operation: Sound waves that kill prostate cancer but spare a man's sex life

Grads of $35,000-a-year prep school were 'masterminds behind heavily-armed drug ring at posh Philadelphia colleges and high schools' that they infiltrated by coaching lacrosse teams Mother who 'hid SEVEN pregnancies from her family and strangled six of the newborns to death' appears in court to tell judge she's broke Medical miracle as man fathers ... (more)


Related Topix: Health, Family, Parenting


Multi-institutional Team Joins Forces to Monitor Genomes of Prostate Tumors Using Blood Biopsies

Cambridge, MA. Mon. April 21, 2014 -- Researchers from MIT's Koch Institute for Integrative Cancer Research, the Broad Institute of MIT and Harvard, and the Dana-Farber Cancer Institute have published a study in Nature Biotechnology demonstrating that new experimental and analytical techniques for studying rare tumor cells in the bloodstream can ... (more)


Related Topix: DanaFarber Cancer Institute, Medicine, Hospital Administration, Healthcare Industry, Genetics, Oncology, Engineering, Chemical Engineering, Science

PhysOrg Weblog

Low adherence rates for prostate cancer quality of care measures

Adherence to established prostate cancer quality of care measures is frequently low, with considerable regional variation, according to a study published in the April issue of The Journal of Urology .


Related Topix: Health, Urology, Medicine, Medicare, Oncology

Courier News

National Cancer Control Month: Steps and screenings to help prevent cancer

This year, more than 1.6 million new cancer cases will be diagnosed, resulting in approximately 586,000 deaths.


Related Topix: Medicine, Health, Breast Cancer, Colorectal Health

Business Journal

Patient advocate groups get increasingly involved in drug development

Sellers is a 15-year prostate cancer survivor. His mother died of lung cancer, and his father had brain cancer.


Related Topix: Health, Lung Cancer, Biotech, Medicine, Millennium Pharmaceuticals, Healthcare Industry

Worcester News

Denise Inge battling cancer

Denise Inge, the wife of the Right Reverend Dr John Inge, is receiving treatment in the sarcoma unit of the Queen Elizabeth Hospital, Birmingham.


Related Topix: Sarcoma, Medicine, Health

Sun Apr 20, 2014


Chronic Inflammation Linked to Prostate Cancer

Chronic inflammation in benign prostate tissue is associated with aggressive prostate cancer, according to a study published in Cancer Epidemiology, Biomarkers, & Prevention , a journal of the American Association for Cancer Research.


Related Topix: Health, Epidemiology

The Advocate

Continue reading a '

According to the National Cancer Institute vaccines are "medicines that boost the immune system's natural ability to protect the body against 'foreign invaders,' mainly infectious agents that may cause disease."


Related Topix: Medicine, Cancer, Healthcare Law, Law, Opinion

The Daily Journal

Some prostate cancer patients abandon 'watchful waiting'

Doctors often recommend no treatment at all when a man is diagnosed with prostate cancer, opting instead to keep a close eye on the slow-growing tumor and acting only when it becomes aggressive.


Related Topix: Health, Medicine, Urology


A Father of Inspiration and Influence

That influential and inspirational person was my father. My mom, dad, brother and I had known my dad had a growth in his prostate but of course, he told us not to worry.


Related Topix: Health

Medical News Today

New nanoparticle created for cancer therapy

For your information: MNT accounts were not affected by the recent Heartbleed bug, as we were not running a vulnerable version of OpenSSL.


Related Topix: Medicine, Cancer, Science / Technology, Nanotechnology, University of Texas at Arlington, Physics, Science

The Spokesman-Review

Motley Fool: Put Johnson & Johnson in long-term portfolio - Sun, 20 Apr 2014 PST

Big blue-chip companies might not grow rapidly, but they can offer more stability than smaller counterparts, and they often pay dividends, too.


Related Topix: Biotech, Johnson and Johnson, Medicine, Healthcare Industry, Tylenol, Tempra, Acetaminophen (generic), Health, Rheumatoid Arthritis, Arthritis, Food and Drug Administration

Sat Apr 19, 2014

The Motley Fool

1 of These 3 Cratering Biotechs is a Buy

At the start of the year, the theme seemed to be that biotech was in for another banner year, propelled by a suite of newly launch drugs that would go on to become blockbusters.


Related Topix: Pancreatic Cancer, Health